Citius Oncology, Inc. (CTOR)
0.8516
+0.06
(+7.50%)
USD |
NASDAQ |
Sep 04, 15:11
Citius Oncology Total Assets (Quarterly) : 112.09M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 112.09M |
| March 31, 2026 | 100.70M |
| December 31, 2025 | 109.97M |
| September 30, 2025 | 100.94M |
| June 30, 2025 | 91.71M |
| March 31, 2025 | 91.44M |
| December 31, 2024 | 90.48M |
| September 30, 2024 | |
| June 30, 2024 | 49.19M |
| March 31, 2024 | 48.68M |
| December 31, 2023 | 72.62M |
| Date | Value |
|---|---|
| September 30, 2023 | 70.71M |
| June 30, 2023 | 69.85M |
| March 31, 2023 | 68.82M |
| December 31, 2022 | 68.19M |
| September 30, 2022 | 0.2817M |
| June 30, 2022 | 0.2356M |
| March 31, 2022 | 0.2114M |
| January 31, 2022 | |
| October 31, 2021 | |
| July 31, 2021 | |
| April 30, 2021 | 0.019M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Citius Pharmaceuticals, Inc. | 142.26M |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 71.71M |
| Shareholders Equity (Quarterly) | 40.38M |
| Debt to Equity Ratio | 0.2528 |
| Current Ratio | 0.7265 |
| Net Debt Paydown Yield | -1.86% |